Clinical Trial

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 23, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
Based on the Phase I trial completed by the sponsor, the Phase II clinical trial aims to investigate the effectiveness and safety of image guidance volume-modulated arc radiation therapy concurrently with Nab-Paclitaxel plus Cisplatin for patients with locally advanced cervical cancer.
Trial Details
NCT Number NCT06426056
Lead Sponsor Peking University Third Hospital
Collaborators: Jilin Provincial Tumor Hospital, Affiliated Hospital of Hebei University, Hebei Medical University Fourth Hospital
Conditions Cervical Cancer
Enrollment 64 participants
Start Date 2024-06
Primary Completion 2025-09 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2024-05-23